Craig R Hoekzema, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1450 Farr Rd, 5000, Norton Shores, MI 49444 Phone: 231-739-9095 Fax: 231-722-5147 |
Dr. Matthew Allen Bowen, M.D. Otolaryngology - Plastic Surgery within the Head & Neck Medicare: Accepting Medicare Assignments Practice Location: 1450 Farr Rd, Norton Shores, MI 49444 Phone: 231-739-9095 Fax: 231-739-6439 |
Dr. Paul Henri Belanger, D.O. Otolaryngology - Otolaryngic Allergy Medicare: Accepting Medicare Assignments Practice Location: 1450 Farr Rd Ste 5000, Norton Shores, MI 49444 Phone: 231-777-2625 Fax: 231-773-8560 |
Arthur James Potter Jr., MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 1450 Farr Rd, Suite 5000, Norton Shores, MI 49444 Phone: 231-739-9095 Fax: 231-722-5147 |
Dr. Paul E Lomeo, DO Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1450 Farr Rd Ste 5000, Norton Shores, MI 49444 Phone: 231-777-2625 Fax: 231-773-8560 |
News Archive
High-intensity step training that mimics real-world conditions may better improve walking ability in stroke survivors compared to traditional, low-impact training, according to new research published in the American Heart Association's journal Stroke.
Physicians found that signs, symptoms and identifiable risk factors are absent in more than half of the mothers of infants with congenital toxoplasmosis in a national study of children with this disease.
University of Maryland School of Medicine (UMSOM) researchers have identified the most toxic proteins made by SARS-COV-2-the virus that causes COVID-19 - and then used an FDA-approved cancer drug to blunt the viral protein's detrimental effects.
Doximity, the professional network for physicians, kicked off a new phase of expansion last week with a ribbon cutting event at its Silicon Valley headquarters. The company is doubling its office space in San Mateo to continue innovating new services for over 250,000 physician members.
The results from three clinical trials have shown that a new drug can successfully delay the progression of Duchenne muscular dystrophy.
› Verified 1 days ago